Anticoagulation is necessary in patients with atrial fibrillation after mitral valve replacement with bioprostheses.
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001705:Bioprosthesis; D005500:Follow-Up Studies; D006349:Heart Valve Diseases / Q000601:surgery*; D006350:Heart Valve Prosthesis; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008943:Mitral Valve / Q000601:surgery*; D011183:Postoperative Complications / Q000188:drug therapy*; D011474:Prosthesis Design; D013923:Thromboembolism / Q000188:drug therapy
D000925:Anticoagulants